How many studies have been conducted on Leukemia Inhibitory Factor?

BiohacksAI has indexed 300 PubMed studies on Leukemia Inhibitory Factor, including 2 randomized controlled trials (RCTs). 17% of studies involve human subjects.

What are the main research areas for Leukemia Inhibitory Factor?

The primary research domains for Leukemia Inhibitory Factor are 🔬 Inflammation, 🛡️ Immunity, 🔬 Oncology. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Leukemia Inhibitory Factor

An INTERLEUKIN-6 related cytokine that exhibits pleiotrophic effects on many physiological systems that involve cell proliferation, differentiation, and survival. Leukemia inhibitory factor binds to and acts through the lif receptor.

300+ PubMed studies analyzed · 2 RCTs · Evidence Score: 45.1

Research Domains

Leukemia Inhibitory Factor has been studied across 23 research domains including 🔬 Inflammation, 🛡️ Immunity, 🔬 Oncology, 🦴 Bone & Joint, 🧬 Hormones. The primary research focus is 🔬 Inflammation with 46% of studies addressing this area.

Loading evidence profile...

This evidence profile for Leukemia Inhibitory Factor is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.